Two distinct buyers come through this page. Pharma teams (direct path) — three engagement models below depending on how much the team wants to drive. Independent agencies (partner path) — license the OVYN engine (Intelligence + Content Engine + Activation), white-label, resell. The fork comes first; the model comes second.
You run DTC marketing for a biotech or pharma brand. You buy direct from OVYN, choose between three engagement models below, and either let our team drive the platform or run it yourself.
You run a PE-backed or boutique pharma agency. Your client is going to ask if you have an AI answer within 12 months. License the engine, white-label it, keep your client relationships and your scope. The production layer becomes leverage instead of liability.
Output quality lands fast. We've heard this on every call. The hesitation is "do I have time to learn a new platform" and "what if my team can't keep this running." Two engagement models answer that — pick the one that fits your team today, switch when you want.
Your account director sits inside the platform every day. You see outputs, approve, and ship. We handle the prompts, the rail tuning, the deployment, the reports.
Same dashboard, your seats. Your team writes the briefs, runs the generator, manages MLR, and configures deployment. OVYN provides the platform, training, ongoing support — you provide the operators.
Months 1–2 are fully managed — OVYN account director on every Zoom, every brief, every approval. Months 3+ progressively hand off, with our team in the platform alongside yours. By month 6, your team owns the daily workflow; we step back to advisory.